2-(3-Phenylpropyl)Pyridine
Common Name: |
2-(3-Phenylpropyl)Pyridine |
IUPAC Name: |
2-(3-phenylpropyl)pyridine |
Molecular Formula: |
C17H16O4 |
SMILES: |
C1=CC=C(C=C1)CCCC2=CC=CC=N2 |
Inchi: |
1S/C14H15N/c1-2-7-13(8-3-1)9-6-11-14-10-4-5-12-15-14/h1-5,7-8,10,12H,6,9,11H2 |
Inchi Key: |
JJJPNTQYUJPWGQ-UHFFFAOYSA-N |
Cas No: |
2110-18-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
284.31 |
Mass (g/mol) |
197.12 |
Molar Refractivity |
78.14 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
7 |
Rings |
2 |
TPSA |
52.60 |
Hetero Atoms |
1 |
Heavy Atoms |
21 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
142.00 to 143.00 @ 1.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.000514 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.18 |
LogP |
3.257 |
iLOGP |
3.27 |
XLOGP3 |
3.76 |
WLOGP |
3.09 |
MLOGP |
3.43 |
ESOL Log S |
-3.93 |
ESOL Solubility (mg/ml) |
0.033 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.56 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-5.13 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.36 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.402 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.129 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
1 |